Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E M Hurt
CD44+CD24− Prostate Cells Are Early Cancer Progenitor/Stem Cells That Provide a Model for Patients With Poor Prognosis
British Journal of Cancer
Cancer Research
Oncology
Related publications
CD44/CD24 and Aldehyde Dehydrogenase 1 in Estrogen Receptor-Positive Early Breast Cancer Treated With Tamoxifen: CD24 Positivity Is a Poor Prognosticator
Oncotarget
Oncology
Prostate Cancer Stem Cells
Clinical Genitourinary Cancer
Oncology
Urology
Basal Epithelial Stem Cells Are Efficient Targets for Prostate Cancer Initiation
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Oct-4 and Nanog Promote the Epithelial-Mesenchymal Transition of Breast Cancer Stem Cells and Are Associated With Poor Prognosis in Breast Cancer Patients
Oncotarget
Oncology
Stem-Like and Highly Invasive Prostate Cancer Cells Expressing CD44v8-10 Marker Originate From CD44-negative Cells
Oncotarget
Oncology
Disseminated Prostate Cancer Cells Can Instruct Hematopoietic Stem and Progenitor Cells to Regulate Bone Phenotype
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype
BMC Cancer
Cancer Research
Oncology
Genetics
The microRNA miR-34a Inhibits Prostate Cancer Stem Cells and Metastasis by Directly Repressing CD44
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Prostate Cancer Stem Cells: Current Understanding
Stem Cells
Medicine
Molecular Medicine
Developmental Biology
Cell Biology
